 |
Previous Article | Next Article 
The Journal of Neuroscience, November 15, 2002, 22(22):9785-9793
Evidence That Synaptically Released -Amyloid Accumulates as
Extracellular Deposits in the Hippocampus of Transgenic Mice
Orly
Lazarov1,
Michael
Lee2,
Daniel A.
Peterson3, and
Sangram S.
Sisodia1
1 Department of Neurobiology, Pharmacology, and
Physiology, The University of Chicago, Chicago, Illinois 60637, 2 Department of Pathology, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, and
3 Department of Neuroscience, The Chicago Medical School,
The Finch University, North Chicago, Illinois 60064
A neuropathological hallmark of Alzheimer's disease is the
deposition of amyloid- (A ) peptides in senile plaques in the hippocampus and cerebral cortex. A is derived from larger integral membrane proteins termed amyloid precursor proteins (APP). We demonstrated previously that APP, synthesized by neurons in the entorhinal cortex, is transported via the perforant pathway to presynaptic terminals in the dentate gyrus. We reported that, although
full-length APP and membrane-tethered, C-terminal APP derivatives
(APP-CTFs) accumulate at terminal fields, the production of A
peptides at these sites was indeterminate. To test the hypothesis that
APP-CTFs, generated from axonally transported APP, are further metabolized to A peptides that are subsequently released and deposited proximal to nerve terminals, we created unilateral knife lesions of the perforant pathway of transgenic mice that exhibit hippocampal amyloid deposits. We observed pronounced reductions in
amyloid burden in the ipsilateral dentate gyrus, findings that lead us
to conclude that axonally transported APP gives rise to A peptides
that are released from presynaptic sites in the dentate gyrus and
deposited in extracellular plaques. Moreover, our findings are
consistent with the view that A deposits are dynamic structures and
that the perforant path lesion alters the equilibrium between A
production-deposition toward clearance as a consequence of blocked
axonal transport of APP from the entorhinal cortex to terminal fields
in the hippocampus.
Key words:
Alzheimer's disease; amyloid precursor protein; amyloid
deposition; perforant pathway; hippocampus; synapse
Copyright © 2002 Society for Neuroscience 0270-6474/02/22229785-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
Z. Wang, B. Wang, L. Yang, Q. Guo, N. Aithmitti, Z. Songyang, and H. Zheng
Presynaptic and Postsynaptic Interaction of the Amyloid Precursor Protein Promotes Peripheral and Central Synaptogenesis
J. Neurosci.,
September 2, 2009;
29(35):
10788 - 10801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Muresan, N. H. Varvel, B. T. Lamb, and Z. Muresan
The Cleavage Products of Amyloid-{beta} Precursor Protein Are Sorted to Distinct Carrier Vesicles That Are Independently Transported within Neurites
J. Neurosci.,
March 18, 2009;
29(11):
3565 - 3578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Perez, S. Lumayag, B. Kovacs, E. J. Mufson, and S. Xu
{beta}-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1{Delta}E9 Transgenic Mouse Model of Alzheimer's Disease
Invest. Ophthalmol. Vis. Sci.,
February 1, 2009;
50(2):
793 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Adalbert, A. Nogradi, E. Babetto, L. Janeckova, S. A. Walker, M. Kerschensteiner, T. Misgeld, and M. P. Coleman
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Brain,
February 1, 2009;
132(2):
402 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-h. Wu, P. Lei, Q. Liu, J. Hu, A. P. Gunn, M.-s. Chen, Y.-f. Rui, X.-y. Su, Z.-p. Xie, Y.-F. Zhao, et al.
Sequestration of Copper from {beta}-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents
J. Biol. Chem.,
November 14, 2008;
283(46):
31657 - 31664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Cole and R. Vassar
The Role of Amyloid Precursor Protein Processing by BACE1, the {beta}-Secretase, in Alzheimer Disease Pathophysiology
J. Biol. Chem.,
October 31, 2008;
283(44):
29621 - 29625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Brody, S. Magnoni, K. E. Schwetye, M. L. Spinner, T. J. Esparza, N. Stocchetti, G. J. Zipfel, and D. M. Holtzman
Amyloid-{beta} Dynamics Correlate with Neurological Status in the Injured Human Brain
Science,
August 29, 2008;
321(5893):
1221 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Fein, S. Sokolow, C. A. Miller, H. V. Vinters, F. Yang, G. M. Cole, and K. H. Gylys
Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease Synaptosomes
Am. J. Pathol.,
June 1, 2008;
172(6):
1683 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mouri, Y. Noda, H. Hara, H. Mizoguchi, T. Tabira, and T. Nabeshima
Oral vaccination with a viral vector containing A{beta} cDNA attenuates age-related A{beta} accumulation and memory deficits without causing inflammation in a mouse Alzheimer model
FASEB J,
July 1, 2007;
21(9):
2135 - 2148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhao, Y. Fu, M. Yasvoina, P. Shao, B. Hitt, T. O'Connor, S. Logan, E. Maus, M. Citron, R. Berry, et al.
{beta}-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis
J. Neurosci.,
April 4, 2007;
27(14):
3639 - 3649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Goldsbury, E. Thies, S. Konzack, and E.-M. Mandelkow
Quantification of Amyloid Precursor Protein and Tau for the Study of Axonal Traffic Pathways
J. Neurosci.,
March 28, 2007;
27(13):
3357 - 3363.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oakley, S. L. Cole, S. Logan, E. Maus, P. Shao, J. Craft, A. Guillozet-Bongaarts, M. Ohno, J. Disterhoft, L. Van Eldik, et al.
Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
J. Neurosci.,
October 4, 2006;
26(40):
10129 - 10140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Huang, A. Mouri, H. Kokubo, R. Nakajima, T. Suemoto, M. Higuchi, M. Staufenbiel, Y. Noda, H. Yamaguchi, T. Nabeshima, et al.
Neprilysin-sensitive Synapse-associated Amyloid-beta Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function
J. Biol. Chem.,
June 30, 2006;
281(26):
17941 - 17951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-B. Zou, A. Mouri, N. Iwata, T. C. Saido, D. Wang, M.-W. Wang, H. Mizoguchi, Y. Noda, and T. Nabeshima
Inhibition of Neprilysin by Infusion of Thiorphan into the Hippocampus Causes an Accumulation of Amyloid beta and Impairment of Learning and Memory
J. Pharmacol. Exp. Ther.,
April 1, 2006;
317(1):
334 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Park, D. A. Gimbel, T. GrandPre, J.-K. Lee, J.-E. Kim, W. Li, D. H. S. Lee, and S. M. Strittmatter
Alzheimer Precursor Protein Interaction with the Nogo-66 Receptor Reduces Amyloid-beta Plaque Deposition
J. Neurosci.,
February 1, 2006;
26(5):
1386 - 1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lazarov, L. D. Peterson, D. A. Peterson, and S. S. Sisodia
Expression of a Familial Alzheimer's Disease-Linked Presenilin-1 Variant Enhances Perforant Pathway Lesion-Induced Neuronal Loss in the Entorhinal Cortex
J. Neurosci.,
January 11, 2006;
26(2):
429 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oddo, A. Caccamo, I. F. Smith, K. N. Green, and F. M. LaFerla
A Dynamic Relationship between Intracellular and Extracellular Pools of A{beta}
Am. J. Pathol.,
January 1, 2006;
168(1):
184 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Perez, O. Lazarov, J. B. Koprich, E.-Y. Chen, V. Rodriguez-Menendez, J. W. Lipton, S. S. Sisodia, and E. J. Mufson
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1{Delta}E9 Transgenic Mice
J. Neurosci.,
November 2, 2005;
25(44):
10220 - 10229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Saura, G. Chen, S. Malkani, S.-Y. Choi, R. H. Takahashi, D. Zhang, G. K. Gouras, A. Kirkwood, R. G. M. Morris, and J. Shen
Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice
J. Neurosci.,
July 20, 2005;
25(29):
6755 - 6764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P.F. Rutten, N. M. Van der Kolk, S. Schafer, M. A.M.J. van Zandvoort, T. A. Bayer, H. W.M. Steinbusch, and C. Schmitz
Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice
Am. J. Pathol.,
July 1, 2005;
167(1):
161 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamamoto, M. Horiba, J. L. Buescher, D. Huang, H. E. Gendelman, R. M. Ransohoff, and T. Ikezu
Overexpression of Monocyte Chemotactic Protein-1/CCL2 in {beta}-Amyloid Precursor Protein Transgenic Mice Show Accelerated Diffuse {beta}-Amyloid Deposition
Am. J. Pathol.,
May 1, 2005;
166(5):
1475 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lazarov, G. A. Morfini, E. B. Lee, M. H. Farah, A. Szodorai, S. R. DeBoer, V. E. Koliatsos, S. Kins, V. M.-Y. Lee, P. C. Wong, et al.
Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited
J. Neurosci.,
March 2, 2005;
25(9):
2386 - 2395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mirnics, Z. Korade, D. Arion, O. Lazarov, T. Unger, M. Macioce, M. Sabatini, D. Terrano, K. C. Douglass, N. F. Schor, et al.
Presenilin-1-Dependent Transcriptome Changes
J. Neurosci.,
February 9, 2005;
25(6):
1571 - 1578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Lee, B. Zhang, K. Liu, E. A. Greenbaum, R. W. Doms, J. Q. Trojanowski, and V. M.-Y. Lee
BACE overexpression alters the subcellular processing of APP and inhibits A{beta} deposition in vivo
J. Cell Biol.,
January 17, 2005;
168(2):
291 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Khvotchev and T. C. Sudhof
Proteolytic Processing of Amyloid-{beta} Precursor Protein by Secretases Does Not Require Cell Surface Transport
J. Biol. Chem.,
November 5, 2004;
279(45):
47101 - 47108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Gylys, J. A. Fein, F. Yang, D. J. Wiley, C. A. Miller, and G. M. Cole
Synaptic Changes in Alzheimer's Disease: Increased Amyloid-{beta} and Gliosis in Surviving Terminals Is Accompanied by Decreased PSD-95 Fluorescence
Am. J. Pathol.,
November 1, 2004;
165(5):
1809 - 1817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Wu, F. Chawla, D. Games, R. E. Rydel, S. Freedman, D. Schenk, W. G. Young, J. H. Morrison, and F. E. Bloom
Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: Digital morphometric analyses
PNAS,
May 4, 2004;
101(18):
7141 - 7146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Iwata, H. Mizukami, K. Shirotani, Y. Takaki, S.-i. Muramatsu, B. Lu, N. P. Gerard, C. Gerard, K. Ozawa, and T. C. Saido
Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-{beta} Peptide in Mouse Brain
J. Neurosci.,
January 28, 2004;
24(4):
991 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhong, Z. Gu, X. Wang, H. Jiang, J. Feng, and Z. Yan
Impaired Modulation of GABAergic Transmission by Muscarinic Receptors in a Mouse Transgenic Model of Alzheimer's Disease
J. Biol. Chem.,
July 11, 2003;
278(29):
26888 - 26896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Reilly, D. Games, R. E. Rydel, S. Freedman, D. Schenk, W. G. Young, J. H. Morrison, and F. E. Bloom
Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model
PNAS,
April 15, 2003;
100(8):
4837 - 4842.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|